跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
AG-OLANZAPINE FC
Authorized
STANDARD
AG-OLANZAPINE FC
angita pharma inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
af08f42b04235b78
Company
angita pharma inc.
Type
Standard
Approval Details
Approval Id
af08f42b04235b78
Drug Approval Canada Name
AG-OLANZAPINE FC
Product Name
AG-OLANZAPINE FC
Status
Dormant
Status Date
2024-07-31
Original Market Date
2020-01-21
Din
02487632
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:16.08.04
Atc Original
N05AH03 OLANZAPINE
Atc Name
n 05 ah 03
Aig Number
0128783002
Company Name
angita pharma inc.
Company Address
1310 Rue Nobel, Boucherville, Quebec, Canada, J4B 5H3
Active Ingredients
OLANZAPINE
10 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
af08f42b04235b78
Type
Standard
Back to Health Canada Approvals
AG-OLANZAPINE FC - Health Canada Drug Approval Details